Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1290636

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1290636

Medical Devices Reimbursement Market, By Payers, By Healthcare Setting, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Medical devices reimbursement is a payment private insurer pays to healthcare providers for costs the provider incurred while using medical devices. Usually, health insurer or government payers cover the patients' healthcare expenses inclusive of medical device use. It is important because it ensures that patients have access to the medical devices they need.

Market Dynamics:

Increasing prevalence of chronic diseases, growing geriatric (aging) population, increasing cost of healthcare, and supportive government initiatives/programs are major factors expected to augment the growth of the global medical devices reimbursement market.

For instance, in November 2022, RQM+ announced the launch of its reimbursement division. RQM+ reimbursement services range from initial reimbursement strategy development to post-approval market access support. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical, and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

Key features of the study:

  • This report provides in-depth analysis of the global medical devices reimbursement market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global medical devices reimbursement market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global medical devices reimbursement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical devices reimbursement market.

Detailed Segmentation:

  • Global Medical Devices Reimbursement Market, By Payers:
    • Public
    • Private
  • Global Medical Devices Reimbursement Market, By Healthcare Setting:
    • Hospitals
    • Outpatient Facilities
    • Others
  • Global Medical Devices Reimbursement Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • BNP Paribas
    • CVS Health
    • Aviva
    • Allianz
    • Humana
    • Cigna
    • Aetna
    • Wellcare Health Plans Inc.
    • UnitedHealth Group Inc.,
    • Nippon Life Insurance Company
Product Code: CMI5755

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Payers
    • Market Snapshot, By Healthcare Setting
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • High prevalence of chronic diseases and growing geriatric population
    • Complex framework and limited coverage and reimbursement
    • Increasing cost of healthcare and supportive government initiatives
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Devices Reimbursement Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Devices Reimbursement Market, By Payers, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Medical Devices Reimbursement Market, By Healthcare Setting, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Outpatient Facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Medical Devices Reimbursement Market, By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Payers, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Healthcare Setting, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • BNP Paribas
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CVS Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aviva
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allianz
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Humana
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cigna
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aetna
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Wellcare Health Plans Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • UnitedHealth Group Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nippon Life Insurance Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!